Roden M - Search Results

1

C-peptide does not affect ocular blood flow in patients with type 1 diabetes.

Polska E, Kolodjaschna J, Berisha F, Malec MM, Simader C, Bayerle-Eder M, Roden M, Schmetterer L. Polska E, et al. Among authors: roden m. Diabetes Care. 2006 Sep;29(9):2034-8. doi: 10.2337/dc06-0134. Diabetes Care. 2006. PMID: 16936149 Clinical Trial.

2

Effect of pravastatin on responsiveness to N-monomethyl-L-arginine in patients with hypercholesterolaemia.

Bayerle-Eder M, Fuchsjäger-Mayrl G, Sieder A, Polska E, Roden M, Stulnig T, Bischof MG, Waldhäusl W, Schmetterer L, Wolzt M. Bayerle-Eder M, et al. Among authors: roden m. Atherosclerosis. 2002 Jan;160(1):177-84. doi: 10.1016/s0021-9150(01)00559-7. Atherosclerosis. 2002. PMID: 11755936 Clinical Trial.

3

Hepatic glycogen metabolism in type 1 diabetes after long-term near normoglycemia.

Bischof MG, Bernroider E, Krssak M, Krebs M, Stingl H, Nowotny P, Yu C, Shulman GI, Waldhäusl W, Roden M. Bischof MG, et al. Among authors: roden m. Diabetes. 2002 Jan;51(1):49-54. doi: 10.2337/diabetes.51.1.49. Diabetes. 2002. PMID: 11756322

4

Renal hemodynamic effects of somatostatin are not related to inhibition of endogenous insulin release.

Schmidt A, Pleiner J, Schaller G, Roden M, Dallinger S, Mayer G, Schmetterer L, Wolzt M. Schmidt A, et al. Among authors: roden m. Kidney Int. 2002 May;61(5):1788-93. doi: 10.1046/j.1523-1755.2002.00320.x. Kidney Int. 2002. PMID: 11967028 Free article. Clinical Trial.

5

FFA-induced endothelial dysfunction can be corrected by vitamin C.

Pleiner J, Schaller G, Mittermayer F, Bayerle-Eder M, Roden M, Wolzt M. Pleiner J, et al. Among authors: roden m. J Clin Endocrinol Metab. 2002 Jun;87(6):2913-7. doi: 10.1210/jcem.87.6.8596. J Clin Endocrinol Metab. 2002. PMID: 12050273 Clinical Trial.

6

Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle.

Anderwald C, Bernroider E, Krssak M, Stingl H, Brehm A, Bischof MG, Nowotny P, Roden M, Waldhäusl W. Anderwald C, et al. Among authors: roden m. Diabetes. 2002 Oct;51(10):3025-32. doi: 10.2337/diabetes.51.10.3025. Diabetes. 2002. PMID: 12351443 Clinical Trial.

7

Diabetic LDL triggers apoptosis in vascular endothelial cells.

Artwohl M, Graier WF, Roden M, Bischof M, Freudenthaler A, Waldhäusl W, Baumgartner-Parzer SM. Artwohl M, et al. Among authors: roden m. Diabetes. 2003 May;52(5):1240-7. doi: 10.2337/diabetes.52.5.1240. Diabetes. 2003. PMID: 12716759

8

Insulin-dependent modulation of plasma ghrelin and leptin concentrations is less pronounced in type 2 diabetic patients.

Anderwald C, Brabant G, Bernroider E, Horn R, Brehm A, Waldhäusl W, Roden M. Anderwald C, et al. Among authors: roden m. Diabetes. 2003 Jul;52(7):1792-8. doi: 10.2337/diabetes.52.7.1792. Diabetes. 2003. PMID: 12829648

9

Increased plasma levels of plasminogen activator inhibitor-1 and soluble vascular cell adhesion molecule after triacylglycerol infusion in man.

Krebs M, Geiger M, Polak K, Vales A, Schmetterer L, Wagner OF, Waldhäusl W, Binder BR, Roden M. Krebs M, et al. Among authors: roden m. Thromb Haemost. 2003 Sep;90(3):422-8. doi: 10.1160/TH03-07-0457. Thromb Haemost. 2003. PMID: 12958610 Clinical Trial.

10

Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus.

Winzer C, Wagner O, Festa A, Schneider B, Roden M, Bancher-Todesca D, Pacini G, Funahashi T, Kautzky-Willer A. Winzer C, et al. Among authors: roden m. Diabetes Care. 2004 Jul;27(7):1721-7. doi: 10.2337/diacare.27.7.1721. Diabetes Care. 2004. PMID: 15220253

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

841 results

Search Page

Filters